These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20720461)

  • 21. Chemoprevention of breast cancer.
    Dalton RR; Kallab AM
    South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing the risk of breast cancer.
    Chlebowski RT
    N Engl J Med; 2000 Jul; 343(3):191-8. PubMed ID: 10900280
    [No Abstract]   [Full Text] [Related]  

  • 23. Emerging bone health issues in women with breast cancer in Hawai'i.
    Carney JF; Davis J
    Hawaii Med J; 2007 Jun; 66(6):164-6. PubMed ID: 17621865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer prevention: present and future.
    Salih AK; Fentiman IS
    Cancer Treat Rev; 2001 Oct; 27(5):261-73. PubMed ID: 11871862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent hormone and radiation therapy in patients with breast cancer: how does chemotherapy affect treatment?
    Yu KD; Shao ZM
    Lancet Oncol; 2009 May; 10(5):442-4; author reply 445-6. PubMed ID: 19410191
    [No Abstract]   [Full Text] [Related]  

  • 26. Aromatase inhibitors in breast cancer.
    Hiscox S; Davies EL; Barrett-Lee P
    Maturitas; 2009 Aug; 63(4):275-9. PubMed ID: 19577386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer risk: the role of the nurse practitioner.
    Kelly PT
    Nurse Pract Forum; 1993 Jun; 4(2):91-5. PubMed ID: 8513269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen for breast cancer prevention.
    Force RW
    J Fam Pract; 1998 Nov; 47(5):336-7. PubMed ID: 9834765
    [No Abstract]   [Full Text] [Related]  

  • 29. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine treatment of breast cancer.
    Ravdin PM
    Curr Ther Endocrinol Metab; 1994; 5():556-62. PubMed ID: 7704791
    [No Abstract]   [Full Text] [Related]  

  • 31. Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.
    Fabian CJ; Kimler BF; Zalles CM; Khan QJ; Mayo MS; Phillips TA; Simonsen M; Metheny T; Petroff BK
    Breast Cancer Res Treat; 2007 Nov; 106(1):75-84. PubMed ID: 17221152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Women at high risk for breast cancer.
    Gross RE
    Am J Nurs; 1998 Apr; 98(4):55-8. PubMed ID: 9556686
    [No Abstract]   [Full Text] [Related]  

  • 33. Endocrine therapy for early breast cancer.
    Hussain SA; Williams S; Stevens A; Rea DW
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):877-88. PubMed ID: 15485321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aromatase inhibitors: potential reproductive implications.
    Bedaiwy MA; Mousa NA; Casper RF
    J Minim Invasive Gynecol; 2009; 16(5):533-9. PubMed ID: 19608462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of breast cancer in the context of a national breast screening programme.
    Howell A; Astley S; Warwick J; Stavrinos P; Sahin S; Ingham S; McBurney H; Eckersley B; Harvie M; Wilson M; Beetles U; Warren R; Hufton A; Sergeant J; Newman W; Buchan I; Cuzick J; Evans DG
    J Intern Med; 2012 Apr; 271(4):321-30. PubMed ID: 22292490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. StatBite: Breast cancer incidence in the U.S. and Italy.
    J Natl Cancer Inst; 2011 Jul; 103(13):1001. PubMed ID: 21737697
    [No Abstract]   [Full Text] [Related]  

  • 37. Have another cup of green tea.
    Nurse Educ; 2011; 36(2):69. PubMed ID: 21330896
    [No Abstract]   [Full Text] [Related]  

  • 38. Breast Cancer Risk Reduction, Version 2.2015.
    Bevers TB; Ward JH; Arun BK; Colditz GA; Cowan KH; Daly MB; Garber JE; Gemignani ML; Gradishar WJ; Jordan JA; Korde LA; Kounalakis N; Krontiras H; Kumar S; Kurian A; Laronga C; Layman RM; Loftus LS; Mahoney MC; Merajver SD; Meszoely IM; Mortimer J; Newman L; Pritchard E; Pruthi S; Seewaldt V; Specht MC; Visvanathan K; Wallace A; Bergman MA; Kumar R
    J Natl Compr Canc Netw; 2015 Jul; 13(7):880-915. PubMed ID: 26150582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanding role of breast cytopathology as a risk predictor.
    Masood S
    Adv Anat Pathol; 2001 Sep; 8(5):255-63. PubMed ID: 11556533
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmaceutical reduction of breast cancer risk.
    Simmons S
    Nurse Pract; 2010 Sep; 35(9):10-1. PubMed ID: 20720461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.